How should I taper lorazepam (Ativan) from 0.5 mg to 0.25 mg tonight?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tapering Lorazepam from 0.5 mg to 0.25 mg Tonight

Reduce your lorazepam dose by 50% tonight (from 0.5 mg to 0.25 mg) as a single step, then hold at 0.25 mg for at least 1-2 weeks before considering further reductions. This follows the widely recommended benzodiazepine tapering principle of 25% dose reductions every 1-2 weeks, though your proposed reduction is more aggressive 1.

Key Tapering Principles

The CDC guidelines explicitly state that benzodiazepines should be tapered gradually because abrupt withdrawal can cause rebound anxiety, hallucinations, seizures, delirium tremens, and in rare cases, death 1. A commonly used safe tapering schedule involves reducing the benzodiazepine dose by 25% every 1-2 weeks 2, 1.

Why This Matters for Your Specific Reduction

  • Your proposed reduction tonight is a 50% decrease (0.5 mg to 0.25 mg), which is more aggressive than the standard 25% recommendation
  • For elderly or debilitated patients, the recommended lorazepam dose is already 0.25-0.5 mg 3, suggesting 0.25 mg is a reasonable target
  • After making this reduction, you should stabilize at 0.25 mg for at least 1-2 weeks before attempting further decreases

Critical Considerations

Duration of Use Matters

  • If you've been taking lorazepam long-term (≥1 year), slower tapers of 10% per month or less are better tolerated than rapid reductions 4
  • The required time for weaning is proportional to the duration of benzodiazepine treatment 5

Withdrawal Symptoms to Monitor

Watch for these signs that indicate you're tapering too quickly:

  • Anxiety, insomnia, irritability
  • Tremor, muscle pain, headache
  • Gastrointestinal symptoms (nausea, vomiting, diarrhea)
  • Tachycardia, diaphoresis
  • More severe: seizures, hallucinations, confusion 4

If you experience clinically significant withdrawal symptoms, this signals the need to slow your taper rate or return to the previous dose 4.

Practical Tapering Strategy

For Tonight's Reduction

  1. Take 0.25 mg instead of 0.5 mg at your usual time
  2. Hold at 0.25 mg for at least 1-2 weeks to allow your body to adjust
  3. Monitor for withdrawal symptoms during this stabilization period

Moving Forward

Recent evidence suggests hyperbolic (proportionate) dose reductions are superior to linear reductions 6. This is because the relationship between benzodiazepine dose and brain receptor activity is hyperbolic—small dose changes at low doses produce larger pharmacological effects than the same absolute dose changes at higher doses.

For your next reduction from 0.25 mg:

  • Consider reducing by 10-25% (to approximately 0.19-0.22 mg)
  • This may require liquid formulations or compounded preparations to achieve such small doses 6, 7
  • The final doses may need to be very small (as little as 0.2 mg diazepam equivalent or less) 6

Common Pitfalls to Avoid

  1. Don't taper too quickly - Withdrawal symptoms can be severe and long-lasting, especially after long-term use 1, 4
  2. Don't abruptly stop - Even at low doses, sudden discontinuation carries seizure risk 1, 8
  3. Don't ignore withdrawal symptoms - These signal the need to slow down or pause the taper 4
  4. Don't assume you're "almost done" - The last reductions are often the most difficult due to hyperbolic dose-response relationships 6

When to Seek Help

  • If withdrawal symptoms become intolerable
  • If you've been on lorazepam for >1 year (may need months-to-years tapering timeline) 4
  • If you have a history of seizures or severe withdrawal reactions
  • If concurrent opioid use is present (benzodiazepine withdrawal carries greater risks than opioid withdrawal) 2, 1

Cognitive behavioral therapy (CBT) increases tapering success rates and should be considered as an adjunctive intervention 2, 1.

Related Questions

Is a taper schedule of reducing diazepam from 30 mg daily to 25 mg for two weeks and then to 20 mg for the next two weeks an appropriate first‑month taper for a patient taking 30 mg daily?
When should I begin tapering lorazepam (Ativan) 0.5 mg after a 10‑day course prescribed for clonidine withdrawal?
Is it safe to taper clonazepam from 2 mg daily to 0.5 mg three times a day after two weeks of use?
What is the recommended taper protocol for clonazepam?
What is an appropriate taper schedule to deprescribe alprazolam (Xanax) for an 83‑year‑old patient with dementia who uses 0.5 mg PRN at night and is on other sedating medications?
What are the differences between empyema thoracis and malignant pleural effusion?
For a patient with metastatic liver cancer who has completed nine cycles of FOLFOX and is experiencing fatigue and neuropathy, should oxaliplatin be discontinued and the continuous 5‑FU infusion switched to oral capecitabine while continuing lenvatinib at the current dose, and what specific lenvatinib dose, capecitabine schedule, tumor‑marker monitoring, and timing of next imaging are recommended?
What are the clinical indications, dosing regimens, contraindications, and common adverse effects of atovaquone?
What are sodium‑glucose co‑transporter‑2 (SGLT2) inhibitors?
What are the recommended dosages and administration schedule for the TCHP regimen (docetaxel, carboplatin, trastuzumab, pertuzumab) in HER2‑positive invasive ductal carcinoma?
What is the best beta‑blocker to administer before hospital arrival for a hemodynamically stable adult with supraventricular tachycardia?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.